Country- and age-specific optimal allocation of dengue vaccines
From MaRDI portal
Publication:2632412
Recommendations
- The optimal age of vaccination against dengue in Brazil based on serotype-specific forces of infection derived from serological data
- The optimal age of vaccination against dengue with an age-dependent biting rate with application to Brazil
- Vaccination models and optimal control strategies to dengue
- Analysis of the optimal vaccination age for dengue in Brazil with a tetravalent dengue vaccine
- A two-age-classes dengue transmission model
Cites work
Cited in
(5)- Optimal dengue vaccination strategies of seropositive individuals
- The optimal age of vaccination against dengue with an age-dependent biting rate with application to Brazil
- The optimal age of vaccination against dengue in Brazil based on serotype-specific forces of infection derived from serological data
- A data-driven spatially-specific vaccine allocation framework for COVID-19
- Analysis of the optimal vaccination age for dengue in Brazil with a tetravalent dengue vaccine
This page was built for publication: Country- and age-specific optimal allocation of dengue vaccines
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2632412)